Media

Corporate Facts

HEADQUARTERS 531 South Spring Street
Burlington, North Carolina 27215
(336) 584-5171
TICKER SYMBOL LH
NUMBER OF EMPLOYEES Nearly 61,000 worldwide
ANNUAL REVENUE $11.3 Billion (2018)
CHIEF EXECUTIVE OFFICER David P. King
PATIENT ACCESS POINTS LabCorp provides patient access points, strategically and conveniently located throughout the U.S., including nearly 2,000 PSCs and more than 6,000 in-office phlebotomists who are located in customer offices and facilities.
LABCORP SPECIALTY TESTING

LabCorp offers a comprehensive menu of frequently requested and specialty tests through an integrated network of primary and specialty laboratories across the United States. The company provides a range of specialty testing services in the areas of women’s health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring. LabCorp’s Specialty Testing Group performs esoteric testing, cancer diagnostics and other complex procedures.

OUR BUSINESS

LabCorp is a leading global life sciences company that is deeply integrated in guiding patient care through its comprehensive clinical laboratory and end-to-end drug development services. The company provides diagnostic, drug development and technology-enabled solutions for more than 120 million patient encounters per year. LabCorp typically processes tests on more than 2.5 million patient specimens per week and serves hundreds of thousands of customers nationwide.  The company’s mission is to improve health and improve lives by delivering world-class diagnostics, accelerating the availability of innovative medicines to patients, and using technology to change the way care is delivered.

Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.

CONTACT PERSON Pattie Kushner
Vice President, Corporate Communications
Phone: 336-436-8263

 

Access the LabCorp corporate backgrounder.

News and Events

Visit LabCorp's Investor Relations site to read about the latest News and Events.

Media Relations Inquiries

For media relations inquiries, please use the following contact information:
336-436-8263
[email protected]

Appropriate contacts

LabCorp (corporate): Pattie Kushner
LabCorp Diagnostics: Don Von Hagen
Covance Drug Development: Sue Maynard